20
Apr 2026
Targeting glutamine metabolism enhances CAR-macrophage cancer therapy
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function.
Stay Informed!
20
Apr 2026
Gut microbiome analysis may help detect Parkinson’s before symptoms appear
Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson's disease, before they have developed any symptoms, suggests a new study led by University College London (UCL) researchers.
20
Apr 2026
Nestlé and NTU Singapore announce research partnership on aging and women's health
Nestlé and NTU Singapore today announced a multi‑year joint research partnership to advance the scientific understanding of how nutrition supports healthy longevity and women's health.
20
Apr 2026
Study finds no benefit of stronger antibiotics for sinusitis
Acute sinusitis leads to more antibiotic prescriptions for U.S. adults than any other condition, but there is no consensus on which antibiotic is preferred for uncomplicated cases.
20
Apr 2026
Simple oral care cuts hospital-acquired pneumonia risk
A landmark trial presented today at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60%.
20
Apr 2026
Scientists disrupt key cancer proteins to target neuroblastoma
Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.
20
Apr 2026
Why Japan saw a major pertussis surge in 2025 while other countries peaked earlier
This study found that pertussis cases fell across Japan, Australia, New Zealand, China, and the USA during COVID-19 restrictions, then resurged afterward, with most countries peaking in 2024 but Japan showing a delayed major outbreak in 2025. In Japan, the surge was concentrated in school-aged children and adolescents, highlighting possible gaps in booster protection and the need to reassess immunization strategies.
20
Apr 2026
CBD shows promise, but this review warns the hype is outpacing the science
A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in treatment-resistant pediatric epilepsy, but evidence for most other uses remains limited, heterogeneous, and not yet mature enough for broad clinical adoption. The authors also warn that poor retail product quality, inaccurate labeling, contaminants, hepatotoxicity risk, and drug interactions are major barriers to safe and effective real-world use.
20
Apr 2026
Study reveals what people ask AI chatbots about health most often
Researchers analyzed more than 500,000 de-identified Microsoft Copilot health conversations from January 2026 and found that health information queries were most common, while nearly one in five conversations involved personal symptoms or condition-related concerns. They also found that personal health queries were more common on mobile and at night, while desktop use was more often tied to research, paperwork, and academic support, highlighting how people use AI differently across contexts.
20
Apr 2026
Certain prenatal medications linked to increased risk of autism
A landmark study led by researchers at the University of Nebraska Medical Center (UNMC) and published in Molecular Psychiatry has identified a significant association between prenatal prescription of commonly utilized medications and the risk of autism spectrum disorder (ASD) in children.
